Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Aris Liakos is active.

Publication


Featured researches published by Aris Liakos.


Diabetes, Obesity and Metabolism | 2014

Efficacy and safety of empagliflozin for type 2 diabetes: a systematic review and meta-analysis.

Aris Liakos; Thomas Karagiannis; Eleni Athanasiadou; Maria Sarigianni; Maria Mainou; Konstantinos Papatheodorou; Eleni Bekiari; Apostolos Tsapas

To assess the efficacy and safety of the novel sodium‐glucose cotransporter 2 (SGLT2) inhibitor empagliflozin compared with placebo or other antidiabetic agents in patients with type 2 diabetes.


Biological Psychiatry | 1990

Factors related to the presence of autoantibodies in patients with chronic mental disorders.

Stavroula Yannitsi; Menelaus N. Manoussakis; Anestis Mavridis; Athanasios G. Tzioufas; Sotirios Loukas; George K. Plataris; Aris Liakos; Haralampos M. Moutsopoulos

Serum samples from 307 patients with various chronic mental disorders were examined for the presence of several autoantibodies. Autoantibodies detected included antinuclear antibodies (ANA) in 122/307 (39.7%), rheumatoid factor (RF) in 23/307 (7.5%), anticardiolipin antibodies (anti-CL) in 23/304 (7.6%, IgM in 12 patients, IgG in 13 patients). Isolated cases with IgG anti-dsDNA, anti-Ro(SSA), and anti-Ro(SSA)/anti-La(SSB) were also identified. The analysis of data revealed that the aging process in patients studied contributed significantly to the incidence of ANA (p less than 0.0001) and RF (p less than 0.01). In addition, the chronic administration of chlorpromazine (CPZ) was associated with the presence of ANA (p less than 0.03) as well as with the presence of IgM and/or IgG anti-CL antibodies (p less than 0.003). Finally, the diagnosis of schizophrenia correlated with the presence of ANA (p less than 0.001). This study represents the autoantibody profile of patients with chronic mental disorders and emphasizes the multifactorial origin of autoantibody response in psychiatric patients.


Journal of Autoimmunity | 1989

Personality structure disturbances and psychiatric manifestations in primary Sjögren's syndrome

Alexandros A. Drosos; Nikiforos V. Angelopoulos; Aris Liakos; Haralampos M. Moutsopoulos

It has been recently suggested that primary Sjögrens syndrome (SS) patients present with a variety of personality structure disturbances and psychiatric symptoms. To evaluate this finding further, we assessed hostility structure and psychiatric symptoms in 33 Sjögrens syndrome patients and compared the results with those of 33 healthy women, and 41 women with solid malignant tumors. The utilized psychometric instruments were the hostility and direction of hostility questionnaire (HDHQ) and the symptom checklist 90R (SCL-90R). High levels of introverted hostility were reported by SS patients in relation to the other two groups. Cancer and SS patients reported higher scores on anxiety and depressive symptoms compared to the healthy women, but the differences were not significant. In addition, high scores on paranoid ideation, somatization and obsessive compulsive symptoms were found in SS patients compared to the cancer and healthy controls. The results strongly suggest that psychiatric disorders are common in primary SS patients, who may need appropriate therapy.


Diabetes, Obesity and Metabolism | 2015

Efficacy and safety of once‐weekly glucagon‐like peptide 1 receptor agonists for the management of type 2 diabetes: a systematic review and meta‐analysis of randomized controlled trials

Thomas Karagiannis; Aris Liakos; Eleni Bekiari; Eleni Athanasiadou; Paschalis Paschos; Despoina Vasilakou; M. Mainou; Maria Rika; Panagiota Boura; David R. Matthews; Apostolos Tsapas

To assess the efficacy and safety of recently approved once‐weekly glucagon‐like peptide 1 receptor agonists (GLP‐1 RAs) in patients with type 2 diabetes.


Clinical Gastroenterology and Hepatology | 2015

Accuracy of Magnetic Resonance Imaging in Diagnosis of Liver Iron Overload: A Systematic Review and Meta-analysis

Maria Sarigianni; Aris Liakos; Efthymia Vlachaki; Paschalis Paschos; Eleni Athanasiadou; Victor M. Montori; Mohammad Hassan Murad; Apostolos Tsapas

BACKGROUND & AIMS Guidelines advocate use of magnetic resonance imaging (MRI) to estimate concentrations of iron in liver, to identify patients with iron overload, and to guide titration of chelation therapy. However, this recommendation was not based on a systematic synthesis and analysis of the evidence for MRIs diagnostic accuracy. METHODS We conducted a systematic review and meta-analysis to investigate the diagnostic accuracy of MRI in identifying liver iron overload in patients with hereditary hemochromatosis, hemoglobinopathy, or myelodysplastic syndrome; liver biopsy analysis was used as the reference standard. We searched MEDLINE and EMBASE databases, the Cochrane Library, and gray literature, and computed summary receiver operating curves by fitting hierarchical models. We assessed methodologic quality using the Quality Assessment of Diagnostic Accuracy Studies 2 tool. RESULTS Our final analysis included 20 studies (819 patients, total). Sensitivity and specificity values varied greatly, ranging from 0.00 to 1.00 and from 0.50 to 1.00, respectively. Because of substantial heterogeneity and variable positivity thresholds, we calculated only summary receiver operating curves (and summary estimate points for studies that used the same MRI sequences). T2 spin echo and T2* gradient-recalled echo MRI sequences accurately identified patients without liver iron overload (liver iron concentration > 7 mg Fe/g dry liver weight) (negative likelihood ratios, 0.10 and 0.05 respectively). However, these MRI sequences are less accurate in establishing a definite diagnosis of liver iron overload (positive likelihood ratio, 8.85 and 4.86, respectively). CONCLUSIONS Based on a meta-analysis, measurements of liver iron concentration by MRI may be accurate enough to rule out iron overload, but not to definitely identify patients with this condition. Most studies did not use explicit and prespecified MRI thresholds for iron overload, therefore some patients may have been diagnosed inaccurately with this condition. More studies are needed of standardized MRI protocols and to determine the effects of MRI surveillance on the development of chronic liver disease and patient survival.


Therapeutic Advances in Endocrinology and Metabolism | 2015

Update on long-term efficacy and safety of dapagliflozin in patients with type 2 diabetes mellitus

Aris Liakos; Thomas Karagiannis; Eleni Bekiari; Panagiota Boura; Apostolos Tsapas

Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a novel class of antihyperglycaemic agents with an insulin-independent mode of action. Dapagliflozin is a member of the SGLT2 inhibitors class that has received marketing authorization in Europe and the US for use in patients with type 2 diabetes. This review summarizes current evidence from clinical trials assessing the clinical efficacy and safety of dapagliflozin, and presents data regarding its cost-effectiveness. Treatment with dapagliflozin results in similar reduction in haemoglobin A1c with other oral antihyperglycaemic drugs, which is preserved over 4 years of treatment. However, compared with most antidiabetic agents, dapagliflozin provides additional clinical benefits including body weight loss and blood pressure reduction. Moreover, treatment with dapagliflozin does not increase risk for hypoglycaemia, but is associated with increased incidence of mild to moderate urinary and genital tract infections. A pivotal outcomes trial of dapagliflozin is expected to clarify its effect on cardiovascular endpoints, whilst a causative relationship between dapagliflozin and select malignancies is unlikely. Finally, based on recent economic evaluations dapagliflozin seems to be a cost-effective option for type 2 diabetes in some settings.


Metabolism-clinical and Experimental | 2014

A simple plaster for screening for diabetic neuropathy: A diagnostic test accuracy systematic review and meta-analysis

Apostolos Tsapas; Aris Liakos; Paschalis Paschos; Thomas Karagiannis; Eleni Bekiari; Nikolaos Tentolouris; Panagiota Boura

OBJECTIVE Neuropad is an adhesive indicator test applied at the plantar surface of the foot that detects sweating through color change. We examined the diagnostic accuracy of this simple plaster as triage test for screening for clinically relevant diabetic sensorimotor polyneuropathy in adult outpatients with type 1 or type 2 diabetes. MATERIALS/METHODS Systematic review and meta-analysis of diagnostic accuracy studies. We searched Medline, Embase, Cochrane Library, Biosis Previews, Web of Science, Scopus and gray literature without date or language restrictions. We pooled estimates of sensitivity and specificity, and fitted hierarchical models to produce summary receiver operating characteristic curves. We assessed methodological quality of included studies utilizing the Quality Assessment of Diagnostic Accuracy Studies 2 tool. RESULTS Eighteen studies with 3470 participants met the inclusion criteria. Average sensitivity and specificity were 86% (95% CI 79 to 91) and 65% (95% CI 51 to 76) respectively. Likelihood ratios (LRs) were LR+=2.44 and LR-=0.22. Subgroup analyses per reference standard utilized provided similar estimates. Most studies were at risk of bias for patient selection and use of index or reference test, and had concerns regarding applicability due to patient selection. CONCLUSION The adhesive indicator test has reasonable sensitivity and could be used for triage of diabetic neuropathy to rule out foot at risk. Patients who tested positive should be referred to specialized care to establish a definite diagnosis. There is insufficient evidence for effectiveness on patient-important outcomes and cost-effectiveness of implementation in the diagnostic pathway compared with the standard clinical examination.


International Journal of Cardiology | 1998

Pain intensity in nondiabetic patients with myocardial infarction or unstable angina. Its association with clinical and psychological features

E Tsouna-Hadjis; G Kallergis; N Agrios; N. Zakopoulos; S Lyropoulos; Aris Liakos; Dimitrios Sideris; Stamatios F. Stamatelopoulos

Sixty nondiabetic coronary artery disease (CAD) patients submitted to coronary angiography were asked to rate (score 0 to 20) pain intensity (RPI) during their last major anginal episode having occurred prior to coronary angiography. This parameter was examined in relation to other variables of CAD and to psychological features. Stepwise regression analysis revealed that RPI was not related to New York Heart Association (NYHA) classification of angina or to angiographic variables. Yet, RPI was found to be significantly affected by psychological features: higher RPI scores were reported by low state anxiety patients (P=0.008), by Type A coronary-prone behavior patients (P=0.02) and by patients with high depression (P=0.03).


European Archives of Psychiatry and Clinical Neuroscience | 1995

Psychiatric morbidity among repatriated greek migrants in a rural area

Nicholas Bilanakis; Michael G. Madianos; Aris Liakos

This paper reports on psychiatric case identification by the application of the Structured Clinical Interview for DSM-III-R (SCID) in a sample of 198 Greek migrants repatriated from western europe in a northwestern province of Greece. The current (1 month) prevalence of psychiatric morbidity, based on the total number of diagnosed cases, was found to be 43.4%. Lifetime prevalence of psychiatric disorders was found to be higher (49.4%). The majority of the sample were diagnosed as suffering from anxiety disorders and dysthymia. Psychiatric disorders were found to be more prevalent among middle-aged respondents. Duration of stay in the foreign country was a factor correlated with psychiatric morbidity. Of short-term migrants 54% were found to suffer from specific nosological entities, whereas 32% of long-term migrants were diagnosed as cases. The results are discussed within the framework of the existing sociocultural context of emigration and repatriation.


International Journal of Cardiology | 2016

Amiodarone and cardiac arrest: Systematic review and meta-analysis

Ageliki Laina; George Karlis; Aris Liakos; Georgios Georgiopoulos; Dimitrios Oikonomou; Evangelia Kouskouni; Athanasios Chalkias; Theodoros Xanthos

INTRODUCTION The 2015 Guidelines for Resuscitation recommend amiodarone as the antiarrhythmic drug of choice in the treatment of resistant ventricular fibrillation or pulseless ventricular tachycardia. We reviewed the effects of amiodarone on survival and neurological outcome after cardiac arrest. METHODS We systematically searched MEDLINE and Cochrane Library from 1940 to March 2016 without language restrictions. Randomized control trials (RCTs) and observational studies were selected. RESULTS Our search initially identified 1663 studies, 1458 from MEDLINE and 205 from Cochrane Library. Of them, 4 randomized controlled studies and 6 observational studies met the inclusion criteria and were selected for further review. Three randomized studies were included in the meta-analysis. Amiodarone significantly improves survival to hospital admission (OR=1.402, 95% CI: 1.068-1.840, Z=2.43, P=0.015), but neither survival to hospital discharge (RR=0.850, 95% CI: 0.631-1.144, Z=1.07, P=0.284) nor neurological outcome compared to placebo or nifekalant (OR=1.114, 95% CI: 0.923-1.345, Z=1.12, P=0.475). CONCLUSIONS Amiodarone significantly improves survival to hospital admission. However there is no benefit of amiodarone in survival to discharge or neurological outcomes compared to placebo or other antiarrhythmics.

Collaboration


Dive into the Aris Liakos's collaboration.

Top Co-Authors

Avatar

Apostolos Tsapas

Aristotle University of Thessaloniki

View shared research outputs
Top Co-Authors

Avatar

Eleni Bekiari

Aristotle University of Thessaloniki

View shared research outputs
Top Co-Authors

Avatar

Thomas Karagiannis

Aristotle University of Thessaloniki

View shared research outputs
Top Co-Authors

Avatar

Eleni Athanasiadou

Aristotle University of Thessaloniki

View shared research outputs
Top Co-Authors

Avatar

Maria Mainou

Aristotle University of Thessaloniki

View shared research outputs
Top Co-Authors

Avatar

Panagiota Boura

Aristotle University of Thessaloniki

View shared research outputs
Top Co-Authors

Avatar

Maria Sarigianni

Aristotle University of Thessaloniki

View shared research outputs
Top Co-Authors

Avatar

Paschalis Paschos

Aristotle University of Thessaloniki

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Anna-Bettina Haidich

Aristotle University of Thessaloniki

View shared research outputs
Researchain Logo
Decentralizing Knowledge